According to Aeterna Zentaris's latest financial reports the company's current revenue (TTM) is $4.49 M. In 2022 the company made a revenue of $5.64 M an increase over the years 2021 revenue that were of $5.26 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $4.49 M | -20.25% |
2022 | $5.64 M | 7.22% |
2021 | $5.26 M | 44.03% |
2020 | $3.65 M | 586.47% |
2019 | $0.53 M | -98.02% |
2018 | $26.88 M | 2812.35% |
2017 | $0.92 M | 1.32% |
2016 | $0.91 M | 67.16% |
2015 | $0.54 M | 4854.55% |
2014 | $0.01 M | -100.02% |
2013 | -$55.4 M | -264.55% |
2012 | $33.66 M | -6.62% |
2011 | $36.05 M | 30.14% |
2010 | $27.7 M | -56.19% |
2009 | $63.23 M | 64.35% |
2008 | $38.47 M | -6.98% |
2007 | $41.36 M | -122.75% |
2006 | -$0.19 B | -176.34% |
2005 | $0.23 B | 25.72% |
2004 | $0.18 B | 50.28% |
2003 | $0.12 B | 94.26% |
2002 | $64.89 M | 135.37% |
2001 | $27.57 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Novartis NVS | $51.01 B | 1,134,004.05% | ๐จ๐ญ Switzerland |
Sanofi SNY | $50.35 B | 1,119,506.78% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $45.00 B | 1,000,478.03% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $25.72 M | 472.01% | ๐บ๐ธ USA |
Halozyme Therapeutics HALO | $0.82 B | 18,336.04% | ๐บ๐ธ USA |